Scrip Regulatory Affairs
China and Taiwan look to closer regulatory ties under new cross-strait pact
17 August 2011
Ian Haydock
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Delay in China's review time for drugs likely to continue; review predictability and transparency improve
- Hatching from the cocoon: US FDA embraces the world
- US IOM calls for more global collaboration to protect drug supply
- European Commission outlines "immediate actions" for member states to improve device safety
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
